LIPUM fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Lipum AB engages in the research and development of novel anti-inflammatory drugs. It focuses in chronic inflammatory diseases. The company was founded by Olle Carl Hernell, Lennart Gustav Lundberg, and Susanne Eva Lindquist on June 17, 2010 and is headquartered in Umea, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
LIPUM does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company